Hepatology
Conference Coverage
Liver injury linked to COVID-19–related coagulopathy
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an...
News
Semaglutide shows promise in NASH phase 2 study
The drug “bodes well for further study” in a condition with no FDA approved treatments.
News
Lipid profiles distinguish obese and nonobese NAFLD patients
Distinct lipid combinations showed noninvasive predictive potential for both obese and nonobese nonalcoholic fatty liver disease patients.
News
NAFLD may predict arrhythmia recurrence post-AFib ablation
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.
News
New CDC guidance for health care personnel exposed to HCV
Baseline testing of the source patient and the HCP should be performed as soon as possible, preferably within 48 hours of exposure.
News
Women suffer less NAFLD but more advanced fibrosis
Compared with men, women have a lower risk of nonalcoholic fatty liver disease, but a higher risk of advanced fibrosis if NAFLD is present.
News
CDC: Screen nearly all adults, including pregnant women, for HCV
News
Noninvasive fibrosis scores not sensitive in people with fatty liver disease and T2D
Alternatives to liver biopsy are less than ideal for detecting advanced fibrosis in patients with underlying diabetes.
News
HCV screening risk factors in pregnant women need updating
Large study of pregnant women highlights the potential value of universal screening for hepatitis C virus.
News
Screen all adults for hepatitis C, says USPSTF
The U.S. Preventive Services Task Force now recommends that asymptomatic adults ages 18-79 be screened for hepatitis C virus infection.